FDA issued a Warning Letter to OHM Pharma, Inc. on 11/19/2019 as a result of this inspection.
483 OHM Pharma May 2019

483 OHM Pharma May 2019

Noreen Muniz FDA$119.00 - Available Now

FDA investigators audited the OHM Pharma - Mineral Wells, TX, United States facility and issued inspectional observations (via FDA 483) on 23 May 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 23 May 2019
  • Location: Mineral Wells, United States
  • FEI: 3003231743
Add To Cart